Viewing Study NCT00003593


Ignite Creation Date: 2025-12-25 @ 1:26 AM
Ignite Modification Date: 2026-01-29 @ 12:12 AM
Study NCT ID: NCT00003593
Status: COMPLETED
Last Update Posted: 2013-06-27
First Post: 1999-11-01
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Chemotherapy in Treating Children With Down Syndrome and Myeloproliferative Disorder, Acute Myelogenous Leukemia, or Myelodysplastic Syndrome
Sponsor: Children's Oncology Group
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Leukemia View
None Myelodysplastic Syndromes View
None Myelodysplastic/Myeloproliferative Neoplasms View
Keywords:

Keywords

Keyword Brief Keyword Text View
None childhood myelodysplastic syndromes View
None untreated childhood acute myeloid leukemia and other myeloid malignancies View
None childhood acute myeloblastic leukemia without maturation (M1) View
None childhood acute myeloblastic leukemia with maturation (M2) View
None childhood acute myelomonocytic leukemia (M4) View
None childhood acute erythroleukemia (M6) View
None childhood acute megakaryocytic leukemia (M7) View
None refractory anemia View
None refractory anemia with ringed sideroblasts View
None refractory anemia with excess blasts View
None refractory anemia with excess blasts in transformation View
None de novo myelodysplastic syndromes View
None childhood acute minimally differentiated myeloid leukemia (M0) View
None childhood acute monocytic leukemia (M5b) View
None childhood acute monoblastic leukemia (M5a) View
None myelodysplastic/myeloproliferative neoplasm, unclassifiable View
None juvenile myelomonocytic leukemia View
None chronic myelomonocytic leukemia View
None secondary myelodysplastic syndromes View